These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 38846614

  • 1. Preference for novel biomedical HIV pre-exposure prophylaxis methods among adolescent girls and young women in Kampala, Uganda: a mixed methods study.
    Mayanja Y, Kayesu I, Kamacooko O, Lunkuse JF, Muturi-Kioi V, Price M, Kosidou K, Ekström AM.
    Front Public Health; 2024; 12():1369256. PubMed ID: 38846614
    [Abstract] [Full Text] [Related]

  • 2. Oral pre-exposure prophylaxis preference, uptake, adherence and continuation among adolescent girls and young women in Kampala, Uganda: a prospective cohort study.
    Mayanja Y, Kamacooko O, Lunkuse JF, Muturi-Kioi V, Buzibye A, Omali D, Chinyenze K, Kuteesa M, Kaleebu P, Price MA.
    J Int AIDS Soc; 2022 May; 25(5):e25909. PubMed ID: 35543110
    [Abstract] [Full Text] [Related]

  • 3. Baseline preferences for oral pre-exposure prophylaxis (PrEP) or dapivirine intravaginal ring for HIV prevention among adolescent girls and young women in South Africa, Uganda and Zimbabwe (MTN-034/IPM-045 study).
    Ngure K, Friedland BA, Szydlo DW, Roberts ST, Garcia M, Levy L, Akello CA, Reddy K, Palanee-Phillips T, Macdonald P, Siziba B, Soto-Torres L, Hosek S, Hillier SL, Nair G, Celum C, van der Straten A.
    PLoS One; 2023 May; 18(6):e0287525. PubMed ID: 37352296
    [Abstract] [Full Text] [Related]

  • 4. Low awareness of oral and injectable PrEP among high-risk adolescent girls and young women in Kampala, Uganda.
    Lunkuse JF, Kamacooko O, Muturi-Kioi V, Chinyenze K, Kuteesa MO, Price MA, Mayanja Y.
    BMC Infect Dis; 2022 May 16; 22(1):467. PubMed ID: 35578163
    [Abstract] [Full Text] [Related]

  • 5. Uptake of and adherence to oral pre-exposure prophylaxis among adolescent girls and young women at high risk of HIV-infection in Kampala, Uganda: A qualitative study of experiences, facilitators and barriers.
    Kayesu I, Mayanja Y, Nakirijja C, Machira YW, Price M, Seeley J, Siu G.
    BMC Womens Health; 2022 Nov 10; 22(1):440. PubMed ID: 36357920
    [Abstract] [Full Text] [Related]

  • 6. Stated product formulation preferences for HIV pre-exposure prophylaxis among women in the VOICE-D (MTN-003D) study.
    Luecke EH, Cheng H, Woeber K, Nakyanzi T, Mudekunye-Mahaka IC, van der Straten A, MTN-003D Study Team.
    J Int AIDS Soc; 2016 Nov 10; 19(1):20875. PubMed ID: 27247202
    [Abstract] [Full Text] [Related]

  • 7. HIV pre-exposure prophylaxis for adolescent girls and young women in Africa: from efficacy trials to delivery.
    Celum CL, Delany-Moretlwe S, Baeten JM, van der Straten A, Hosek S, Bukusi EA, McConnell M, Barnabas RV, Bekker LG.
    J Int AIDS Soc; 2019 Jul 10; 22 Suppl 4(Suppl Suppl 4):e25298. PubMed ID: 31328444
    [Abstract] [Full Text] [Related]

  • 8. Examining concordance of sexual-related factors and PrEP eligibility with HIV risk perception among adolescent girls and young women: cross-sectional insights from DREAMS sites in Kenya, Malawi, and Zambia.
    Heck CJ, Reed DM, Okal J, Chipeta E, Mbizvo M, Mathur S.
    BMC Public Health; 2024 Oct 12; 24(1):2793. PubMed ID: 39395932
    [Abstract] [Full Text] [Related]

  • 9. The Community PrEP Study: a randomized control trial leveraging community-based platforms to improve access and adherence to pre-exposure prophylaxis to prevent HIV among adolescent girls and young women in South Africa-study protocol.
    Medina-Marino A, Bezuidenhout D, Hosek S, Barnabas RV, Atujuna M, Bezuidenhout C, Ngwepe P, Peters RPH, Little F, Celum CL, Daniels J, Bekker LG.
    Trials; 2021 Jul 26; 22(1):489. PubMed ID: 34311754
    [Abstract] [Full Text] [Related]

  • 10. Integrating preexposure prophylaxis delivery in routine family planning clinics: A feasibility programmatic evaluation in Kenya.
    Mugwanya KK, Pintye J, Kinuthia J, Abuna F, Lagat H, Begnel ER, Dettinger JC, John-Stewart G, Baeten JM, PrEP Implementation for Young Women and Adolescents (PrIYA) Program.
    PLoS Med; 2019 Sep 26; 16(9):e1002885. PubMed ID: 31479452
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. HIV prevention at drug shops: awareness and attitudes among shop dispensers and young women about oral pre-exposure prophylaxis and the dapivirine ring in Shinyanga, Tanzania.
    Tubert J, Packel L, Hunter LA, Mfaume R, Njau P, Ramadhani AA, Liu JX, McCoy SI.
    AIDS Res Ther; 2021 Apr 26; 18(1):21. PubMed ID: 33902623
    [Abstract] [Full Text] [Related]

  • 13. A multi-country cross-sectional study to assess predictors of daily versus on-demand oral pre-exposure prophylaxis in youth from South Africa, Uganda and Zimbabwe.
    Dietrich JJ, Ahmed N, Webb EL, Tshabalala G, Hornschuh S, Mulaudzi M, Atujuna M, Stranix-Chibanda L, Nematadzira T, Ssemata AS, Muhumuza R, Seeley J, Bekker LG, Weiss HA, Martinson N, Fox J, CHAPS team.
    J Int AIDS Soc; 2022 Aug 26; 25(8):e25975. PubMed ID: 36002910
    [Abstract] [Full Text] [Related]

  • 14. Patterns of HIV Pre-exposure Prophylaxis use Among Adolescent Girls and Young Women Accessing Routine Sexual and Reproductive Health services in South Africa.
    Martin CE, Cox LA, Nongena P, Butler V, Ncube S, Sawry S, Mullick S.
    J Adolesc Health; 2023 Dec 26; 73(6S):S81-S91. PubMed ID: 37953014
    [Abstract] [Full Text] [Related]

  • 15. High Awareness, Yet Low Uptake, of Pre-Exposure Prophylaxis Among Adolescent Girls and Young Women Within Family Planning Clinics in Kenya.
    Sila J, Larsen AM, Kinuthia J, Owiti G, Abuna F, Kohler PK, John-Stewart G, Pintye J.
    AIDS Patient Care STDS; 2020 Aug 26; 34(8):336-343. PubMed ID: 32757980
    [Abstract] [Full Text] [Related]

  • 16. Perceptions of and interest in HIV pre-exposure prophylaxis use among adolescent girls and young women in Lilongwe, Malawi.
    Maseko B, Hill LM, Phanga T, Bhushan N, Vansia D, Kamtsendero L, Pettifor AE, Bekker LG, Hosseinipour MC, Rosenberg NE.
    PLoS One; 2020 Aug 26; 15(1):e0226062. PubMed ID: 31929547
    [Abstract] [Full Text] [Related]

  • 17. Exploring adolescent girls and young women's PrEP-user profiles: qualitative insights into differentiated PrEP delivery platform selection and engagement in Cape Town, South Africa.
    Rousseau E, Sikkema KJ, Julies RF, Mazer K, O'Malley G, Heffron R, Morton JF, Johnson R, Celum C, Baeten JM, Bekker LG.
    J Int AIDS Soc; 2024 May 26; 27(5):e26254. PubMed ID: 38695101
    [Abstract] [Full Text] [Related]

  • 18. Adolescent Girls and Young Women's Experiences with Disclosing Oral PrEP or Dapivirine Vaginal Ring Use: a Multi-Country Qualitative Analysis.
    Young AM, Mancuso N, Atujuna M, Tenza S, Chitukuta M, Kemigisha D, Ngure K, van der Straten A, Garcia M, Szydlo D, Soto-Torres L, Roberts ST.
    AIDS Behav; 2023 Dec 26; 27(12):3941-3951. PubMed ID: 37392268
    [Abstract] [Full Text] [Related]

  • 19. Factors that influence adolescent girls and young women's re-initiation or complete discontinuation from daily oral PrEP use: a qualitative study from Eastern Cape Province, South Africa.
    de Vos L, Mudzingwa EK, Fynn L, Atujuna M, Mugore M, Gandhi M, Celum C, Hosek S, Bekker LG, Daniels J, Medina-Marino A.
    J Int AIDS Soc; 2023 Sep 26; 26(9):e26175. PubMed ID: 37758649
    [Abstract] [Full Text] [Related]

  • 20. Continued attendance in a PrEP program despite low adherence and non-protective drug levels among adolescent girls and young women in Kenya: Results from a prospective cohort study.
    Tapsoba JD, Cover J, Obong'o C, Brady M, Cressey TR, Mori K, Okomo G, Kariithi E, Obanda R, Oluoch-Madiang D, Chen YQ, Drain P, Duerr A.
    PLoS Med; 2022 Sep 26; 19(9):e1004097. PubMed ID: 36095005
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.